Real-time financial, economic, and global news with market-focused context and analysis.
Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.
Gen IV Investment Opportunities and related entities sold 2,369,769 shares of Battalion Oil Corp (NASDAQ: BATL) on March 25, 2026, for $5.8206 per share, generating proceeds of $13,793,477. The filing shows the reporting owners no longer hold any Battalion shares. The transaction comes as the stock has exhibited extreme short-term swings and the co…
Glaukos NASDAQ:GKOS Senior Vice President and Chief Financial Officer Alex R. Thurman sold 2,511 shares on March 25, 2026, for $106.46 per share, totaling $267,321, under a Rule 10b5-1 trading plan. The transaction left Thurman with 41,967 shares held directly, including 5,230 unvested restricted stock units. On the same date he recorded acquisitio…
Dave & Buster's Entertainment Inc CEO Tarun Lal executed two purchases totaling $69,690 for the company’s common stock in September and October 2025. The transactions — 2,500 shares at $20.52 on September 18 and 1,000 shares at $18.39 on October 21 — leave Lal with 11,560 shares directly held. The stock has since fallen to $9.81, close to its 52-we…
Anaptysbio President and CEO Daniel Faga sold 16,571 shares on March 27, 2026, to meet tax withholding obligations tied to recently vested performance-based restricted stock units. The company is moving ahead with a planned April 20, 2026 spinoff of First Tracks Biotherapeutics, which raised $80 million in a private placement, and its board has app…
Director Juan Jose Chacon Quiros sold 3,575 shares of Establishment Labs Holdings Inc. (NASDAQ: ESTA) on March 25, 2026, in a transaction totaling approximately $214,768. The sale was executed under a pre-arranged Rule 10b5-1 trading plan. Separately, Establishment Labs reported fourth-quarter 2025 results that exceeded expectations, with an EPS of…
Battery X Metals Inc. filed an amended Form F-1 with the U.S. Securities and Exchange Commission on March 18, 2026, advancing its proposed initial public offering on a U.S. national securities exchange. The Vancouver company revised its confidential draft registration to address SEC comments on prior submissions; it has not set the number of shares…
Adam Crystal, President of R&D at Tango Therapeutics (TNGX), sold 12,000 shares on March 25, 2026, realizing roughly $241,320, and simultaneously exercised options to acquire 12,000 shares at a $5.20 strike. The transactions were carried out under a Rule 10b5-1 plan adopted on October 27, 2025. Tango reported a net loss of $38.7 million in Q4 2025 …
Apogee Therapeutics CFO Jane Henderson sold 2,000 shares of the company’s common stock on March 25, 2026, for $85.00 per share, netting $170,000. The transaction was executed under a Rule 10b5-1 trading plan adopted on September 2, 2025. The move comes amid a flurry of capital-raising activity by the company and after an analyst raised its price ta…
On March 27 the Federal Aviation Administration ordered a halt to air traffic at the region's primary airports after an odor was detected at the Potomac Consolidated Terminal RADAR Approach Control (TRACON) facility in Warrenton, Virginia. The evacuation of the facility led to ground stops at Reagan Washington National, Washington Dulles, Baltimore…
Rocket Lab successfully launched its 85th mission, marking the first dedicated launch for the European Space Agency (ESA) using its Electron launch vehicle. The 'Daughter Of The Stars' mission delivered ESA's Celeste satellites to low Earth orbit to demonstrate enhanced satellite navigation alongside Europe's Galileo constellation. This success und…
Alumis Inc. reported positive Phase 3 results for envudeucitinib, its oral TYK2 inhibitor, demonstrating robust skin clearance, rapid improvements in quality of life and itch relief, and a favorable safety profile in patients with moderate-to-severe plaque psoriasis. Data from two pivotal trials ONWARD1 and ONWARD2 indicate sustained efficacy throu…
Priovant Therapeutics, a Roivant company, reported positive Phase 3 trial results for brepocitinib in dermatomyositis, showing statistically significant improvements over placebo in multiple efficacy endpoints including muscle strength, skin disease, physical function, and corticosteroid reduction. Results were published in the New England Journal …
Biogen announced positive Phase 2 results from the AMETHYST study for litifilimab, an investigational monoclonal antibody targeting BDCA2, demonstrating statistically significant improvement in skin disease activity in patients with cutaneous lupus erythematosus (CLE). These consistent positive results, along with a favorable safety profile and FDA…
CoreWeave CEO and President Michael N. Intrator sold 42,693 shares of Class A stock on March 25, 2026, collecting $7,202,031 in proceeds. The trades, executed under a Rule 10b5-1 plan adopted May 23, 2025, occurred at prices between $85.5971 and $88.2534. Intrator still holds 5,666,501 shares directly following the transactions. On the same day he …
Inspired Entertainment Director Michael R. Chambrello bought $69,240 worth of common stock on March 26, 2026, bringing his direct holdings to 64,568 shares. The purchases occurred while the stock traded below InvestingPro's fair value estimate; the company reported fourth-quarter 2025 results that beat revenue expectations but missed on EPS, and pr…
James H. Dahl, listed as a 10% owner of AMREP CORP (NASDAQ: AXR), bought 4,000 shares on March 26, 2026, spending $105,210 across multiple trades executed between $25.4356 and $27.164 per share. The purchases raise his direct stake to 474,398 shares while he also holds additional shares indirectly through IRAs and a trust. The stock has returned 38…
Sandeep Bharathi, president of Marvell Technology's Data Center Group, sold 44,414 shares on March 26, 2026, for about $4.42 million under a 10b5-1 plan. The transaction came as Marvell introduced the Structera S 60260 PCIe 6.0 switch, declared a quarterly dividend, and retained Buy ratings from Stifel and UBS amid its partnerships and revenue targ…
Inspired Entertainment President and CEO Pierce Brooks H. completed a series of open-market purchases March 25-27, 2026, totaling $136,633. The trades increased his direct and indirect holdings in the company amid mixed fourth-quarter results and a continued analyst Market Outperform rating with an $11.00 price target.
The NASDAQ Composite has moved into correction territory as the U.S. military conflict with Iran intensifies, prompting the steepest valuation pressure on the technology sector since the dotcom era. Capital Economics analysts characterize the downturn as a temporary repricing of inflated valuations rather than the onset of systemic earnings deterio…
Protagonist Therapeutics' Chief Financial Officer, Ali Asif, sold 24,765 shares of the company's common stock on March 26, 2026, for roughly $2.58 million at $104.24 per share. On the same day he exercised options to acquire an identical number of shares across two grants. The company recently received FDA approval for its psoriasis treatment Icoty…
Protagonist Therapeutics director Harold E. Selick exercised options to buy 24,000 shares at $12.88 and sold those shares along with an additional 24,000 shares on March 26, 2026, generating proceeds of $2.52 million from the stock sale and $309,120 tied to the option exercise. The share transactions occurred with the stock trading near its 52-week…
Arturo Molina, M.D., the chief medical officer of Protagonist Therapeutics (PTGX), sold 15,000 shares of common stock on March 26, 2026, generating about $1.57 million. Molina also exercised options to acquire 15,000 shares at $8.04. The trades come as Protagonist shares have climbed sharply following FDA approval of Icotyde (icotrokinra), promptin…
Weil A Lorne, Executive Chairman of Inspired Entertainment, Inc. (NASDAQ: INSE), acquired 50,000 shares of the company’s common stock across three transactions from March 25 to March 27, 2026, totaling roughly $339,915. The purchases occurred while the shares traded near a 52-week low of $6.10 and followed a quarter in which the company missed EPS …
Sonya Morris, a director of PIMCO Municipal Income Fund II (PML), purchased 5,000 common shares on March 25, 2026, at $7.4779 per share for a total of approximately $37,389. The trade leaves Morris with direct ownership of 5,000 shares. The transaction occurred while PML shares were trading near their 52-week low of $7.10 and are quoted at $7.35. T…
Japan Post Holdings Co., Ltd. sold 14,200 shares of Aflac Inc. on March 25, 2026, generating $1,519,826 at a weighted average price of $107.03. The transaction leaves Japan Post with an indirect stake of 52,018,600 Aflac shares. Aflac reported mixed fourth-quarter 2025 results with an EPS shortfall and a revenue beat, and Mizuho adjusted its price …
